FDA Revokes EUA for Battelle Decontamination System
Last week the FDA revoked the emergency use authorization (EUA) granted to Battelle’s Critical Care Decontamination System (CCDS). The agency’s move was made after Battelle requested the voluntary withdrawal of the authorization and confirmed that it stopped the operation of the CCDS at sites, along with any marketing activities.
Battelle received the EUA on March 28, 2020 during a time of critical need during the beginning of the COVID-19 pandemic. It was authorized to decontaminate a N95 mask up to 20 times.
Related Articles
-
Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.
-
The CERSI program was established to foster robust and innovative approaches to advance regulatory science through collaborative interactions with FDA scientific experts.
-
As of June 1, 2022, the Center for Devices and Radiological Health plans to accept all non-COVID in vitro diagnostic (IVD) pre-submissions.
-
The FDA CDRH is seeking input from industry and the public on expanding access to home use medical technologies. The comment period closes on August 30, 2023.
